Search Results - "Yuskin, Diane"

Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action by Levy, Odile E, Jodka, Carolyn M, Ren, Shijun Steven, Mamedova, Lala, Sharma, Abhinandini, Samant, Manoj, D'Souza, Lawrence J, Soares, Christopher J, Yuskin, Diane R, Jin, Li Jenny, Parkes, David G, Tatarkiewicz, Krystyna, Ghosh, Soumitra S

“…The design, synthesis and pharmacology of novel long-acting exenatide analogs for the treatment of metabolic diseases are described. These molecules display…”
Get full text

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization by Thomsen, William J, Grottick, Andrew J, Menzaghi, Frederique, Reyes-Saldana, Hazel, Espitia, Stephen, Yuskin, Diane, Whelan, Kevin, Martin, Michael, Morgan, Michael, Chen, Weichao, Al-Shamma, Hussien, Smith, Brian, Chalmers, Derek, Behan, Dominic

“…5-Hydroxytryptamine (5-HT)(2C) receptor agonists hold promise for the treatment of obesity. In this study, we describe the in vitro and in vivo characteristics…”
Get more information

Discovery and Structure−Activity Relationship of 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine2A Receptor Inverse Agonist for the Treatment of Arterial Thrombosis by Xiong, Yifeng, Teegarden, Bradley R, Choi, Jin-Sun Karoline, Strah-Pleynet, Sonja, Decaire, Marc, Jayakumar, Honnappa, Dosa, Peter I, Casper, Martin D, Pham, Lan, Feichtinger, Konrad, Ullman, Brett, Adams, John, Yuskin, Diane, Frazer, John, Morgan, Michael, Sadeque, Abu, Chen, Weichao, Webb, Robert R, Connolly, Daniel T, Semple, Graeme, Al-Shamma, Hussien

“…Serotonin, which is stored in platelets and is released during thrombosis, activates platelets via the 5-HT2A receptor. 5-HT2A receptor inverse agonists thus…”
Get full text

Discovery and Structure−Activity Relationship of 3-Methoxy- N -(3-(1-methyl-1 H -pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine 2A Receptor Inverse Agonist for the Treatment of Arterial Thrombosis by Xiong, Yifeng, Teegarden, Bradley R., Choi, Jin-Sun Karoline, Strah-Pleynet, Sonja, Decaire, Marc, Jayakumar, Honnappa, Dosa, Peter I., Casper, Martin D., Pham, Lan, Feichtinger, Konrad, Ullman, Brett, Adams, John, Yuskin, Diane, Frazer, John, Morgan, Michael, Sadeque, Abu, Chen, Weichao, Webb, Robert R., Connolly, Daniel T., Semple, Graeme, Al-Shamma, Hussien

Get full text

Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action: e87704 by Levy, Odile E, Jodka, Carolyn M, Ren, Shijun Steven, Mamedova, Lala, Sharma, Abhinandini, Samant, Manoj, D'Souza, Lawrence J, Soares, Christopher J, Yuskin, Diane R, Jin, Li Jenny

“…The design, synthesis and pharmacology of novel long-acting exenatide analogs for the treatment of metabolic diseases are described. These molecules display…”
Get full text